Filing Flows › Cannapharmarx (CPMD) › Q2 2026
Cannapharmarx (CPMD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 18, 2026
Cannapharmarx (CPMD) reported revenue of $276K for the second quarter 2026 (Q2 2026), +19% from a year earlier and -56% from the quarter before. Operating margin was -137.1%, net loss $1.9M (691.1% of revenue).
Cannapharmarx, Q2 2026: revenue $276K (+19% year over year), operating margin -137.1%, net loss $1.9M, operating cash flow −$127K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $276K | -56% | +19% |
| Operating profit | −$379K | — | — |
| Net earnings | −$1.9M | — | — |
| Operating cash flow | −$127K | — | — |
What changed
Revenue was $276K in Q2 2026, up 19% year over year and down 56% from the previous quarter.
Operating costs exceeded revenue by $379K, an operating margin of -137.1%. Total costs fell 39% while revenue rose 19%. The quarter ended with a net loss of $1.9M, wider than the previous quarter's $382K loss. Net interest and other expense of $1.5M was the main reason.
Operating cash flow was −$127K. Working capital and other items added $1.8M.
Questions
What was Cannapharmarx's revenue in the second quarter 2026?
Cannapharmarx (CPMD) reported revenue of $276K for the second quarter 2026 (Q2 2026), +19% from a year earlier and -56% from the quarter before.
Was Cannapharmarx profitable in the second quarter 2026?
Operating loss was $379K (-137.1% of revenue) and net loss $1.9M.
Source: Cannapharmarx 10-Q on SEC EDGAR.